GlassScriptPhysician profile
Daniel William Cook
NPI 1447872643
$808.20
in general payments reported to CMS, 2019-2025
20 companies · $43.49 in 2025
The $43.49 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $765 · 2025: $43.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $216.95 | 2021 | |
| Amarin Pharma, INC. | $83.20 | 2021 | |
| Novo Nordisk INC | $69.01 | 2021 | |
| Mannkind Corporation | $53.70 | 2021 | |
| Corcept Therapeutics | $42.53 | 2021 | |
| Vifor Pharma, INC. | $34.14 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.57 | 2021 | |
| Merck Sharp & Dohme LLC | $28.64 | 2021-2025 | Zerbaxa |
| Medtronic, INC. | $28.01 | 2025 | Plasmablade(Tm) |
| Astrazeneca Pharmaceuticals LP | $26.29 | 2021 | |
| Esperion Therapeutics, INC. | $26.08 | 2021 | |
| Daiichi Sankyo INC. | $23.47 | 2021 | |
| Zealand Pharma US, INC. | $22.56 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.15 | 2021 | |
| Tandem Diabetes Care, INC. | $20.82 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $20.55 | 2021 | |
| Radius Health, INC. | $16.99 | 2021 | |
| Insulet Corporation | $15.67 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.14 | 2021 | |
| Clarus Therapeutics INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.